David Hickey's most recent trade in Becton, Dickinson And Co. was a trade of 9,213 Stock Appreciation Rights done . Disclosure was reported to the exchange on Nov. 26, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 9,213 | 9,213 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,024 | 12,237 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,663 | 5,862 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 3,883 | 0 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.54 per share. | 11 Aug 2023 | 3,883 | 9,030 (0%) | 0% | 132.5 | 514,653 | Common Stock |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 277.85 per share. | 11 Aug 2023 | 2,974 | 4,199 (0%) | 0% | 277.9 | 826,326 | Common Stock |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Sale or transfer of securities back to the company at price $ 277.85 per share. | 11 Aug 2023 | 1,857 | 7,173 (0%) | 0% | 277.8 | 515,967 | Common Stock |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 10,975 | 10,975 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,816 | 5,147 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,125 | 12,100 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 265.00 per share. | 15 Aug 2022 | 475 | 3,331 (0%) | 0% | 265 | 125,875 | Common Stock |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 256.00 per share. | 06 May 2022 | 475 | 3,806 (0%) | 0% | 256 | 121,600 | Common Stock |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 10,522 | 10,522 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,511 | 5,366 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,473 | 5,059 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 08 Sep 2021 | 500 | 3,586 (0%) | 0% | 260 | 130,000 | Common Stock |
| Becton, Dickinson & Company | David Hickey | EVP & President, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Sep 2021 | 268 | 4,086 (0%) | 0% | 0 | Common Stock |